Cargando…
Safety signals of albumin-bound paclitaxel: Data mining of the Food and Drug Administration adverse event reporting system
BACKGROUND: With the extensive application of paclitaxel for injection (albumin-bound), its adverse reactions have also received increasing attention. AIM: This study aims to provide a reference for the safe use of albumin-bound paclitaxel in clinical practice; adverse drug events signals of albumin...
Autores principales: | Wang, Yuwei, Liu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501543/ https://www.ncbi.nlm.nih.gov/pubmed/37555411 http://dx.doi.org/10.4103/ijp.ijp_640_22 |
Ejemplares similares
-
Adverse event profiles of solvent-based and nanoparticle
albumin-bound paclitaxel formulations using the Food and Drug Administration
Adverse Event Reporting System
por: Naganuma, Misa, et al.
Publicado: (2019) -
Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
por: Tian, Zhichao, et al.
Publicado: (2022) -
A Retrospective Study of Efficacy and Safety of Albumin-Bound Paclitaxel in Metastatic Breast Cancer
por: Singh, Rajesh Kumar, et al.
Publicado: (2014) -
Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancer
por: TAKASHIMA, SEIKI, et al.
Publicado: (2015) -
Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
por: Hassan, Md Sazzad, et al.
Publicado: (2018)